0 Items
Select Page

Hepatitis E

Hepatitis E virus (HEV) is a small positive sense, single-stranded RNA virus. HEV is currently the only representative of the hepevirus genus, belonging to the family Hepeviridae. Four genotypes 1-4 of the Hepatitis E virus have been identified so far, with each genotype having a different geographical distribution. Transmission of HEV primarily occurs via the faecal-oral route, through contaminated food or water, but can be transmitted through blood transfusion products in some cases.

In healthy individuals, Hepatitis E is an asymptomatic or self-limiting disease. However, patient with a pre-existing chronic liver disease and pregnant women have an increased risk of liver failure and death. Diagnosis of HEV is achieved using serological and molecular methods of detection.

Hepatitis E Background

Hepatitis E virus (HEV) is a small positive sense, single-stranded RNA virus. HEV is currently the only representative of the hepevirus genus, belonging to the family Hepeviridae. Four genotypes 1-4 of the Hepatitis E virus have been identified so far, with each genotype having a different geographical distribution. HEV genotype 1 and 2 are restricted to humans and are found in Africa and Asia, whereas genotype 3 is found worldwide and genotype 4 is found in China and Japan. Both genotypes 3 and 4 generally circulate in animals including pigs, wild boar, deer and rabbits but can also infect humans (WHO).

Transmission of HEV primarily occurs via the faecal-oral route, through contaminated food or water. Infection through contaminated water is a typical route of transmission for HEV genotypes 1 and 2, particularly in endemic areas with poor sanitation. Infections involving HEV genotypes 3 and 4 have been linked to the consumption of undercooked pork and meat from infected animals. Reports suggest that HEV may also be transmitted via transfused blood products in areas where the virus is endemic.

In healthy individuals, Hepatitis E is an asymptomatic or self-limiting disease which can last for up to two weeks after the incubation period of 2-9 weeks. Symptoms can include fatigue, nausea, loss of appetite, abdominal pain, aching joints, slight hepatomegaly and numbness in arms and legs. Immunosuppressed patients infected with HEV may develop chronic liver disease after initial infection. In addition, patient with a pre-existing chronic liver disease and pregnant women have an increased risk of liver failure and death. Reports suggest that the risk of miscarriage, liver failure and death can increase during the second and third trimester of pregnancy.

HEV infection emerging as a significant disease of global health concern. Currently there is no effective treatment for HEV infection, although Ribavirin has been shown. to benefit immunosuppressed patients. A single vaccine has been developed and licensed for the prevention of HEV infection, which is under review by the World Health Organization.

 

References

World Health Organization: Fact sheets; Hepatitis E

Hepatitis E Antigens

Our Hepatitis E antigens include highly purified preparations of ORF2 with different purification tags. These antigens are suitable for use in assay development, vaccine research and for the preparation of Hepatitis E antibodies.

Hepatitis E Antibodies

Our monoclonal Hepatitis E antibodies target the HEV capsid (ORF2) and are suitable for use in diagnostic assay development and vaccine research.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

A Q&A with David Flavell of Leukaemia Busters

In this blog, we speak with Dr. David Flavell about his scientific career, the legacy of Leukaemia Busters, and the recent impact that COVID-19 has had on his research.Tell me about your scientific background David. I was born in a seaside town called Southport in...

Avoiding the Immunopathology Pitfalls of a COVID-19 Vaccine

In the second of a three-part series on COVID-19 vaccines, we explore the potential challenges in stimulating safe vaccine responses and outline the role that diagnostics will play in guiding their development.Rogue Responses Antibodies play a crucial role in...

The Bumpy Road to a Cytomegalovirus Vaccine

The development of a cytomegalovirus vaccine has been 50 years in the making. Are there any technologies in the pipeline that could prompt a breakthrough? This article was originally posted online at The Medicine Maker, a Texere publication.To say that...

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

13 + 10 =

Live Customer Feedback

Join our mailing list

* indicates required